# clm_BF8A71350904

subject: Amgen (/record/amgen.md)  
predicate: total_equity  
value: 6,700,000,000 United States dollar  
valid_from: 2021-12-31  
valid_to: 2022-03-31  
published: 2022-02-16  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_68A37D10302E  
last_updated: 2026-11-08  
cite: AsOf. "Amgen total equity: 6,700,000,000 United States dollar", as of 2021-12-31 (until 2022-03-31). Claim clm_BF8A71350904, https://asof.is/claim/clm_BF8A71350904, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/318154/000031815422000010/0000318154-22-000010-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:StockholdersEquity in 10-K FY2021, filed 2022-02-16  

## Sources

- https://www.sec.gov/Archives/edgar/data/318154/000031815422000010/0000318154-22-000010-index.htm (primary, SEC EDGAR 10-K FY2021, published 2022-02-16)

## Supersedes

- [Amgen](/record/amgen.md) | total_equity | 8,217,000,000 United States dollar | valid 2021-09-30 to 2021-12-31 | conf 0.95 | superseded | superseded_by [clm_BF8A71350904](/claim/clm_BF8A71350904.md) | [clm_6DC2B1698886](/claim/clm_6DC2B1698886.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.